Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Stardust Power Reports Preliminary 2025 Results and Highlights Development Progress at Muskogee Lithium Refinery
-
ROHM has Introduced Reference Designs for Three-Phase Inverters Featuring New SiC Power Modules
-
In HelloNation, Water Conditioning Expert Nathan Scheopner of Garden City, KS, Explains Reverse Osmosis Benefits
-
Grizzly Closes 1st Tranche of Private Placement
-
OraSure Highlights Significant Operational Progress and Value Creation Initiatives Following Letter from Altai Capital
-
Boundless Bio Announces Upcoming Presentation of Oral Kinesin Degrader Program at the American Association for Cancer Research Annual Meeting 2026
-
What Should Multi-Unit Restaurant Operators Look for When Switching POS Systems? Lavu Publishes 2026 Buyer’s Guide
-
In HelloNation, Home Renovation Expert Tim Buehler Explains What Monroe, Wisconsin, Homeowners Should Know Before Starting a Kitchen Remodel
-
Calumet Completes Offering of $150 Million of Additional 9.75% Senior Notes due 2031
-
Pentera Earns 5-Star Recognition in CRN® Partner Program Guide
-
Star Equity Holdings Reports 2025 Fourth Quarter and Full-Year Results
-
Leading the Next Chapter in Legal Licensure: BARBRI's NextGen Bar Review Now Open
-
Juice Labs Joins NVIDIA AI Grid Ecosystem, Delivering the Connectivity Fabric for Distributed Intelligence at the Telco Edge
-
Caring for the Body, PLLC Launches Physician-Led Re-Think Aging Platform to Advance a New Era of Cognitive Decline Prevention and Longevity Care
-
JPMorganChase Declares Common Stock Dividend
-
Brenig Therapeutics Announces Oral Presentation of Phase 1 Data for BT-267 at AD/PD™ 2026, and Provides Updates on BT-409, its NLRP3 Inhibitor Program
-
Paragon Home Care Addresses What Families Should Know Before Hiring a Home Caregiver in McLean, VA
-
Mountain Province Diamonds Extends Maturity on Credit Facility and Provides Update on Cash Call Arrears
-
The Body Shop to Accelerate Product Innovation with Centric PLM
-
First Farmers and Merchants Corporation Declares Quarterly Cash Dividend of $0.29 Per Share
-
Perspective Therapeutics Announces Acceptance of VMT-α-NET Data for Presentation at the AACR Annual Meeting 2026
-
Greystone Housing Impact Investors LP Schedules Fourth Quarter 2025 Earnings Conference Call and Issues Investor Schedule K-1s
-
Xilio Therapeutics to Present New Preclinical Data for its Masked T Cell Engager Program Targeting CLDN18.2 at the American Association for Cancer Research (AACR) Annual Meeting
-
Verastem Oncology Announces Abstracts Accepted for Presentation on AVMAPKI™ FAKZYNJA™ (avutometinib capsules; defactinib tablets) Combination Therapy at the Society of Gynecologic Oncology 2026 An
-
Mr. Rooter Plumbing of North Miami Beach Surpasses 100 Google Reviews with 5-Star Rating
-
JPMorganChase to Host First-Quarter 2026 Earnings Call
-
CHIPOTLE MEXICAN GRILL TO ANNOUNCE FIRST QUARTER 2026 RESULTS ON APRIL 29, 2026
-
Fifth Third Bancorp Announces Cash Dividends
-
PSE&G Applauds FERC Decision Protecting Its Customers From Unfair Transmission Costs
-
Agenus Announces Upcoming AACR 2026 Presentation Evaluating Botensilimab Plus Balstilimab in First-Line MSS Metastatic Colorectal Cancer
-
Greystone Provides $46 Million Bridge-to-HUD Loan for Seniors Housing Portfolio in Ohio
-
Texas King Haul LLC Expands Dump Truck and Material Delivery Services Across Houston Construction Market
-
Tonix Pharmaceuticals Announces Oral Presentation and Two Poster Presentations on Preclinical Immuno-oncology Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026
-
Nuvation Bio to Present Pivotal IBTROZI® (Taletrectinib) Data in TKI-Naïve and TKI-Pretreated Patients with Advanced ROS1-Positive Non-Small Cell Lung Cancer at AACR 2026
-
Zai Lab to Present New Data on Three Internally Developed Oncology Candidates at AACR 2026, Including Zocilurtatug Pelitecan, a DLL3-Targeting Antibody-Drug Conjugate (ADC)
-
Beyond Cancer Reports Early Clinical Activity and Favorable Safety Profile with Interim Data from Phase 1 UNO Trial
-
Dollar Surge Weighs on Gold’s Rally
-
Synthekine Announces AACR 2026 Oral Presentation of Updated Phase 1a/1b Clinical and Translational Data for STK‑012 in First‑Line Nonsquamous NSCLC with Features of Immunotherapy Resistance
-
Immuneering to Present Molecular Data at 2026 AACR Annual Meeting from Atebimetinib-Treated Patients, Highlighting Mechanism Designed to Improve Durability and Survival
-
Adagene’s Muzastotug (ADG126) to be Highlighted in Two Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting in San Diego, CA
-
UnitedHealth Group Announces Earnings Release Date
-
Sportradar to Participate in the 38th Annual Roth Conference
-
Elbit Systems Announces the Filing of its Annual Report on Form 20-F for Fiscal Year 2025
-
Fulgent Genetics Completes Acquisition of Bako Diagnostics and StrataDx
-
Exact Sciences to Present New Molecular Residual Disease and Multi-Cancer Early Detection Data at AACR 2026
-
Prelude Therapeutics Announces Acceptance of Preclinical Abstract for PRT13722, a First-in-Class Oral KAT6A Selective Degrader at the 2026 AACR Annual Meeting
-
Immunitas Therapeutics to Present Clinical Data Supporting Monotherapy and Combination Treatment Potential of IMT-009 at the AACR 2026 Annual Meeting
-
Oklo’s Atomic Alchemy Announces U.S. Department of Energy Approval for Nuclear Safety Design Agreement of its Groves Isotopes Test Reactor
-
Zentalis Pharmaceuticals to Present Two Posters at the American Association for Cancer Research (AACR) Annual Meeting 2026
-
SingleCell Biotechnology to Present High-Throughput Single-Cell Phenotyping Platform at AACR Annual Meeting
